Ticker: DCTH

Delcath Systems, Inc. (NASDAQ: DCTH) - Q2 2025 Financial Overview Delcath Systems, Inc., a biopharmaceutical company and leader in the treatment of cancers affecting the liver, has recently released its financial report for the quarter ending June 30, 2025. The company has shown significant progr...